The Mistery of Ketamine: The Misleading Conclusion of a Randomized Controlled Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Mistery of Ketamine: The Misleading Conclusion of a Randomized Controlled Trial

Published:2024-09 Issue:3 Volume:68 Page:e232-e233
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

Mercadante Sebastiano

Publisher

Elsevier BV

Reference8 articles.

1. Should subanaesthetic ketamine be considered when managing opioid refractory cancer pain?;Poon;J Pain Symptom Manage,2024

2. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain;Hardy;J Clin Oncol,2012

3. Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine;Hardy;Intern Med J,2014

4. Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial;McCaffrey;Aust Health Rev,2016

5. An intravenous ketamine test as a predictive response tool in opioid exposed patients with persistent pain;Cohen;J Pain Symptom Manage,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3